168 related articles for article (PubMed ID: 22539990)
1. Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.
Wu Y; Li Q; Zhou X; Yu J; Mu Y; Munker S; Xu C; Shen Z; Müllenbach R; Liu Y; Li L; Gretz N; Zieker D; Li J; Matsuzaki K; Li Y; Dooley S; Weng H
PLoS One; 2012; 7(4):e35684. PubMed ID: 22539990
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
[TBL] [Abstract][Full Text] [Related]
4. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated smad2 in advanced stage gastric carcinoma.
Shinto O; Yashiro M; Toyokawa T; Nishii T; Kaizaki R; Matsuzaki T; Noda S; Kubo N; Tanaka H; Doi Y; Ohira M; Muguruma K; Sawada T; Hirakawa K
BMC Cancer; 2010 Nov; 10():652. PubMed ID: 21110833
[TBL] [Abstract][Full Text] [Related]
6. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
8. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
11. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
[TBL] [Abstract][Full Text] [Related]
12. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.
Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W
J Biol Chem; 2021; 296():100512. PubMed ID: 33676893
[TBL] [Abstract][Full Text] [Related]
13. Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.
Tsukada T; Fushida S; Harada S; Terai S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2013 Apr; 42(4):1167-74. PubMed ID: 23443842
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
17. Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
Miyamoto S; Fukui T; Horitani S; Tanimura Y; Matsumoto Y; Suzuki R; Takahashi YU; Kishimoto M; Tomiyama T; Nishio A; Okazaki K; Naganuma M
Anticancer Res; 2021 Oct; 41(10):4789-4799. PubMed ID: 34593428
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern and phosphorylation status of Smad2/3 in different subtypes of human first trimester trophoblast.
Haider S; Kunihs V; Fiala C; Pollheimer J; Knöfler M
Placenta; 2017 Sep; 57():17-25. PubMed ID: 28864007
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
